About Voluntis
Voluntis is a company based in Cambridge (United States) founded in 2001 was acquired by Aptar in July 2021. Voluntis has raised $31.19 million across 3 funding rounds from investors including Aptar, Bpifrance and Qualcomm Ventures. Voluntis offers products and services including Theraxium Platform and Digital Solutions for Life Sciences. Voluntis operates in a competitive market with competitors including Welldoc, DarioHealth, Wellthy Therapeutics, Pear Therapeutics and Liva Healthcare, among others.
- Headquarter Cambridge, United States
- Stage Public
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Voluntis
Voluntis offers a comprehensive portfolio of products and services, including Theraxium Platform and Digital Solutions for Life Sciences.
Provides personalized algorithms for patient treatment enhancement
Offers clinical design and regulatory support for pharma partners
Funding Insights of Voluntis
Voluntis has successfully raised a total of $31.19M across 3 strategic funding rounds. The most recent funding activity was a Post-IPO round of $7.11 million completed in November 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Voluntis
Voluntis has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include Aptar, Bpifrance and Qualcomm Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investing in technology sectors such as AI and automotive.
|
Locked | Locked | Locked | |
|
Life sciences-focused VC firm investing in Europe and Canada
|
Locked | Locked | Locked | |
|
Growth and acquisition investments are managed by Credit Mutuel Equity.
|
Locked | Locked | Locked |
Investor details for Voluntis
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Voluntis
Investment portfolio details for Voluntis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Voluntis
Detailed financials for Voluntis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Voluntis Comparisons
Peer comparison for Voluntis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Voluntis
Voluntis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Welldoc, DarioHealth, Wellthy Therapeutics, Pear Therapeutics and Liva Healthcare, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Mobile health products for chronic disease management are offered.
|
|
| Locked | Locked | Locked |
Chronic conditions are managed via a personalized digital platform.
|
|
| Locked | Locked | Locked |
Health monitoring app is provided for chronic patients and providers.
|
|
| Locked | Locked | Locked |
Pear Therapeutics provides cloud-based digital solutions for managing chronic health conditions effectively.
|
|
| Locked | Locked | Locked |
Chronic care management solutions are provided for patients and professionals.
|
|
| Locked | Locked | Locked |
Asthma and COPD symptoms are managed through clinical services.
|
Detailed competitors of Voluntis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Voluntis
Complete news archive for Voluntis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Voluntis
Voluntis was founded in 2001 and raised its 1st funding round 6 years after it was founded.
Voluntis is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Voluntis is a funded company, having raised a total of $31.19M across 3 funding rounds to date.
Voluntis was founded in 2001 and is based in Cambridge, United States. A remote monitoring platform is offered to healthcare providers in the digital health sector. Therapeutic education is delivered to patients with chronic diseases, while compliance is ensured and adverse events are followed up. Clinical data management and software solutions are also provided to support ongoing patient care and operations.
Voluntis's top competitors include Welldoc, Wellthy Therapeutics and DarioHealth.
Voluntis offers Theraxium Platform and Digital Solutions for Life Sciences.
Voluntis has 7 investors. Key investors include Aptar, Bpifrance, Qualcomm Ventures, Vesalius Biocapital Partners, and Innovation Capital.